Cessatech A/S

Hjem
Danmark
Hellerup
Cessatech A/S

Developing evidence based medicine

21/08/2025

Today we released our Q2 financial report, marking the end of an extremely busy and rewarding quarter. We finalized the Clinical and CMC program for CT001 and completed our Marketing Authorisation Application (MAA) in record time. In addition, our new US manufacturing setup has made excellent progress, and we look forward to sharing more updates later this year. A huge thank you to our team and partners for their amazing effort and dedication!
https://cessatech.com/wp-content/uploads/2025/08/Q2_2025-Report_final-.pdf

15/08/2025

We are very pleased to announce that the Marketing Authorisation Application (MAA) for CT001 has been submitted to the European Medicines Agency (EMA) for acute pain management in children - thanks to a great effort from everyone !
https://cessatech.com/marketing-authorisation-application-maa-for-ct001-has-been-submitted-to-the-european-medicines-agency-ema-for-acute-pain-management-in-children/

Adresse

Strandvejen 60
Hellerup
2900

Internet side

http://www.cessatech.com/

Underretninger

Vær den første til at vide, og lad os sende dig en email, når Cessatech A/S sender nyheder og tilbud. Din e-mail-adresse vil ikke blive brugt til andre formål, og du kan til enhver tid afmelde dig.

Genveje

Vil du plassere din praksis på toppen av Klinik-listen i Hellerup?

Del

Type

Lægemiddelvirksomhed